Unchained Labs Sets the Hook on Automated Buffer Exchange with Lil’ Tuna
July 7, 2026
Pleasanton, CA — Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched Lil’ Tuna today, the first fully automated, plate-based, benchtop buffer exchange system. Unchained’s been automating buffer exchange forever — with Big Tuna for plate exchanges and Unagi for walk-up processing of individual samples. [...]
July 7, 2026
SAN DIEGO -- Nucleus Biologics, the leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, today announced the launch of CRAIC™ Formulation Finder, a large language model (LLM) assistant that helps scientists identify, develop, and optimize cell culture media and buffer formulations for their novel cell ecosystem. Rather than searching literature, [...]
NTx Bio Introduces NTxscribe FLEX: Continuous-Flow RNA Production That Scales to Your Workflow
July 7, 2026
New, more flexible and affordable benchtop system is designed for the flexibility and customizability demanded by preclinical research, process development, and translational applications RIO RANCHO, N.M. -- NTx Bio, a leader in next-generation biomanufacturing technologies, today introduced NTxscribe® FLEX, a flexible benchtop continuous-flow RNA production system designed to serve the needs of process development scientists, translational researchers, [...]
July 6, 2026
Partnership with Hamburg Trading Corp to advance applied testing and life science research Serving as a learning hub to empower the next generation of Filipino scientists through hands-on access to molecular workflows Facility designed to remove logistical barriers for researchers, enabling on-site evaluation without the need for internal equipment clearances Singapore, Singapore – QIAGEN, a [...]
Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer
July 6, 2026
Former Bionano Genomics Chief Medical Officer joins Nabsys at a pivotal moment as the Company expands commercialization of its electronic genome mapping platform Dr. Chaubey will lead medical and scientific affairs strategy as Nabsys works to expand global access to high-resolution structural variant analysis for cancer, constitutional, and cell and gene therapy applications PROVIDENCE, R.I. -- Nabsys [...]
July 6, 2026
Seer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation Highly Qualified, Independent and Accountable Board Has Taken Decisive Action to Advance Stockholders’ Best Interests Board Urges Stockholders to Vote “FOR” ONLY Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif. -- Seer, Inc. (Nasdaq: [...]
Changes to the Board of Directors and notice of Extraordinary General Meeting
July 6, 2026
Board Chair Maria Rankka has today notified the Board of Directors that she will step down as Board Chair and board member of BICO Group AB (publ) effective 31 July 2026. Board members Susanne Lithander and Johan Westman have also informed the Board that they will leave their Board assignments at the same time. The [...]
July 6, 2026
NEW YORK and FREDERICK, Md. -- Surplus Solutions LLC ("Surplus Solutions"), a portfolio company of NMS Capital ("NMS"), announced today the acquisition of DCM BioServices ("DCM Bio" or the "Company"), a Frederick, Maryland-based provider of laboratory automation maintenance, repair, technical support, and integration solutions. The acquisition expands Surplus Solutions' technical service capabilities and supports the [...]
Leica Microsystems Advances AI-Powered Analysis for Multi-well Assays with Aivia 16
July 6, 2026
Software enhancements help researchers simplify complex studies and generate results with confidence Wetzlar, Germany – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, announced today the release of Aivia 16, the newest version of its AI-powered image analysis software, helping researchers analyze complex multi-well assay data faster and with [...]
Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer
July 6, 2026
Former Bionano Genomics Chief Medical Officer joins Nabsys at a pivotal moment as the Company expands commercialization of its electronic genome mapping platform Dr. Chaubey will lead medical and scientific affairs strategy as Nabsys works to expand global access to high-resolution structural variant analysis for cancer, constitutional, and cell and gene therapy applications PROVIDENCE, R.I. -- Nabsys [...]

